TATA POWER: CO SIGNS MOU WITH BPCL TO DEVELOP 110 KV POWER INFRASTRUCTURE FOR ITS LANDMARK PRFCCU PROJECT AT MUMBAI REFINER
β€1
SKY GOLD & DIAMONDS Q2 FY27
Net Profit: βΉ129 Cr β93% YoY | β23% QoQ
Revenue: βΉ2,391 Cr β61% YoY | β19% QoQ
Other Income: βΉ14 Cr vs βΉ8 Cr YoY | βΉ8 Cr QoQ
EPS: βΉ8.26 β89% YoY | β24% QoQ
Net Profit: βΉ129 Cr β93% YoY | β23% QoQ
Revenue: βΉ2,391 Cr β61% YoY | β19% QoQ
Other Income: βΉ14 Cr vs βΉ8 Cr YoY | βΉ8 Cr QoQ
EPS: βΉ8.26 β89% YoY | β24% QoQ
β€2
IRIS CLOTHINGS Q2 FY27 (STANDALONE)
Net Profit: βΉ5 Cr β23% YoY | β27% QoQ
Revenue: βΉ62 Cr β40% YoY | β32% QoQ
EBITDA: βΉ9 Cr β34% YoY | β17% QoQ
EBITDA Margin: 15.1% vs 15.9% YoY | 17.0% QoQ
Net Profit: βΉ5 Cr β23% YoY | β27% QoQ
Revenue: βΉ62 Cr β40% YoY | β32% QoQ
EBITDA: βΉ9 Cr β34% YoY | β17% QoQ
EBITDA Margin: 15.1% vs 15.9% YoY | 17.0% QoQ
VARDHMAN SPECIAL STEELS Q2 FY27 (STANDALONE)
Net Profit: βΉ52 Cr β52% YoY | β27% QoQ
Revenue: βΉ600 Cr β39% YoY | β23% QoQ
Other Income: βΉ15 Cr vs βΉ11 Cr YoY | βΉ10 Cr QoQ
Operating Profit: βΉ69 Cr β53% YoY | β18% QoQ
Operating Profit Margin: 11.5% vs 10.5% YoY | 12.0% QoQ
EPS: βΉ5.42 β51% YoY | β28% QoQ
Net Profit: βΉ52 Cr β52% YoY | β27% QoQ
Revenue: βΉ600 Cr β39% YoY | β23% QoQ
Other Income: βΉ15 Cr vs βΉ11 Cr YoY | βΉ10 Cr QoQ
Operating Profit: βΉ69 Cr β53% YoY | β18% QoQ
Operating Profit Margin: 11.5% vs 10.5% YoY | 12.0% QoQ
EPS: βΉ5.42 β51% YoY | β28% QoQ
INDOCO REMEDIES Q2 FY27 (CONS.)
Net Profit: βΉ19.47 Cr vs βΉ9.21 Cr loss YoY | β70.25% QoQ
Revenue: βΉ520.17 Cr β7.32% YoY | β11.27% QoQ
EBITDA: βΉ46.43 Cr β7.85% YoY | β13.19% QoQ
EBITDA Margin: 8.93% vs 8.88% YoY | 8.77% QoQ
Other Income: βΉ2 Cr vs βΉ1 Cr YoY | βΉ2 Cr QoQ
EPS: βΉ2.11 β311% YoY | β70% QoQ
Net Profit: βΉ19.47 Cr vs βΉ9.21 Cr loss YoY | β70.25% QoQ
Revenue: βΉ520.17 Cr β7.32% YoY | β11.27% QoQ
EBITDA: βΉ46.43 Cr β7.85% YoY | β13.19% QoQ
EBITDA Margin: 8.93% vs 8.88% YoY | 8.77% QoQ
Other Income: βΉ2 Cr vs βΉ1 Cr YoY | βΉ2 Cr QoQ
EPS: βΉ2.11 β311% YoY | β70% QoQ
ACUTAAS CHEMICALS Q2 FY27 (CONS.)
Net Profit: βΉ123.14 Cr β71.37% YoY | β64.21% QoQ
Revenue: βΉ436.92 Cr β42.69% YoY | β32.53% QoQ
EBITDA: βΉ179.95 Cr β87.52% YoY | β185.31% QoQ
EBITDA Margin: 41.19% vs 31.34% YoY | 19.13% QoQ
Other Income: βΉ6 Cr vs βΉ8 Cr YoY | βΉ4 Cr QoQ
EPS: βΉ15.39 β74% YoY | β70% QoQ
Net Profit: βΉ123.14 Cr β71.37% YoY | β64.21% QoQ
Revenue: βΉ436.92 Cr β42.69% YoY | β32.53% QoQ
EBITDA: βΉ179.95 Cr β87.52% YoY | β185.31% QoQ
EBITDA Margin: 41.19% vs 31.34% YoY | 19.13% QoQ
Other Income: βΉ6 Cr vs βΉ8 Cr YoY | βΉ4 Cr QoQ
EPS: βΉ15.39 β74% YoY | β70% QoQ
ACUTAAS:
CO REVISE FY27 REVENUE GROWTH GUIDANCE UPWARD FROM 25% TO AROUND 30%. RAISING EBITDA MARGIN GUIDANCE TO 38-40% RANGE.
CO REVISE FY27 REVENUE GROWTH GUIDANCE UPWARD FROM 25% TO AROUND 30%. RAISING EBITDA MARGIN GUIDANCE TO 38-40% RANGE.
DYNAMIC CABLES Q2 FY27
Net Profit: βΉ22.15 Cr β12.82% YoY | β11.22% QoQ
Revenue: βΉ363.19 Cr β28.99% YoY | β4.04% QoQ
EBITDA: βΉ36.35 Cr β10.76% YoY | β4.34% QoQ
EBITDA Margin: 10.01% vs 11.66% YoY | 10.88% QoQ
Net Profit: βΉ22.15 Cr β12.82% YoY | β11.22% QoQ
Revenue: βΉ363.19 Cr β28.99% YoY | β4.04% QoQ
EBITDA: βΉ36.35 Cr β10.76% YoY | β4.34% QoQ
EBITDA Margin: 10.01% vs 11.66% YoY | 10.88% QoQ
APPLE IPHONE SALES IN INDIA FALL UP TO 30% DURING FESTIVE SEASON; HIGHER PRICES, WEAKER PROMOTIONS HIT DEMAND
CIPLA Q2 FY27
Net Profit: βΉ852 Cr β37% YoY | β8% QoQ
Revenue: βΉ7,404 Cr β2% YoY | β4% QoQ
Other Income: βΉ151 Cr vs βΉ269 Cr YoY | βΉ211 Cr QoQ
Operating Profit: βΉ1,388 Cr β27% YoY | β16% QoQ
Operating Profit Margin: 18.7% vs 25.0% YoY | 16.7% QoQ
EPS: βΉ10.86 β35% YoY | β11% QoQ
Net Profit: βΉ852 Cr β37% YoY | β8% QoQ
Revenue: βΉ7,404 Cr β2% YoY | β4% QoQ
Other Income: βΉ151 Cr vs βΉ269 Cr YoY | βΉ211 Cr QoQ
Operating Profit: βΉ1,388 Cr β27% YoY | β16% QoQ
Operating Profit Margin: 18.7% vs 25.0% YoY | 16.7% QoQ
EPS: βΉ10.86 β35% YoY | β11% QoQ
CIPLA Q2 FY27 : ACTUAL VS ESTIMATES
β’ Net Profit: βΉ852 Cr vs βΉ949 Cr est. β MISS BY 10.22% π΄
β’ Revenue: βΉ7,404 Cr vs βΉ7,498 Cr est. β MISS BY 1.25% π΄
β’ EBITDA: βΉ1,388 Cr vs βΉ1,371 Cr est. β BEAT BY 1.24% π’
β’ EBITDA Margin: 18.7% vs 18.3% est. β BEAT BY 40 BPS π’
β’ Net Profit: βΉ852 Cr vs βΉ949 Cr est. β MISS BY 10.22% π΄
β’ Revenue: βΉ7,404 Cr vs βΉ7,498 Cr est. β MISS BY 1.25% π΄
β’ EBITDA: βΉ1,388 Cr vs βΉ1,371 Cr est. β BEAT BY 1.24% π’
β’ EBITDA Margin: 18.7% vs 18.3% est. β BEAT BY 40 BPS π’
BHARAT SEATS Q2 FY27 (STANDALONE)
Net Profit: βΉ15 Cr β54% YoY | β15% QoQ
Revenue: βΉ709 Cr β55% YoY | β23% QoQ
Other Income: βΉ1 Cr vs βΉ3 Cr YoY | βΉ1 Cr QoQ
Operating Profit: βΉ32 Cr β41% YoY | β13% QoQ
Operating Profit Margin: 4.5% vs 4.9% YoY | 4.9% QoQ
EPS: βΉ2.42 β53% YoY | β15% QoQ
Net Profit: βΉ15 Cr β54% YoY | β15% QoQ
Revenue: βΉ709 Cr β55% YoY | β23% QoQ
Other Income: βΉ1 Cr vs βΉ3 Cr YoY | βΉ1 Cr QoQ
Operating Profit: βΉ32 Cr β41% YoY | β13% QoQ
Operating Profit Margin: 4.5% vs 4.9% YoY | 4.9% QoQ
EPS: βΉ2.42 β53% YoY | β15% QoQ
β€1
BHARAT BIJLEE Q2 FY27 (STANDALONE)
β’ Net Profit: βΉ46 Cr β63% YoY | β135% QoQ
β’ Revenue: βΉ736 Cr β55% YoY | β35% QoQ
β’ Operating Profit: βΉ59 Cr β69% YoY | β104% QoQ
β’ Margin: 8.0% vs 7.4% YoY | 5.3% QoQ
β’ EPS: βΉ40.73 β63% YoY | β134% QoQ
β’ Net Profit: βΉ46 Cr β63% YoY | β135% QoQ
β’ Revenue: βΉ736 Cr β55% YoY | β35% QoQ
β’ Operating Profit: βΉ59 Cr β69% YoY | β104% QoQ
β’ Margin: 8.0% vs 7.4% YoY | 5.3% QoQ
β’ EPS: βΉ40.73 β63% YoY | β134% QoQ
KIRLOSKAR PNEUMATIC Q2 FY27
Net Profit: βΉ40 Cr β9% YoY | β20% QoQ
Revenue: βΉ326 Cr β16% YoY | β8% QoQ
Other Income: βΉ8 Cr vs βΉ7 Cr YoY | βΉ8 Cr QoQ
EPS: βΉ3.08 β8% YoY | β20% QoQ
Net Profit: βΉ40 Cr β9% YoY | β20% QoQ
Revenue: βΉ326 Cr β16% YoY | β8% QoQ
Other Income: βΉ8 Cr vs βΉ7 Cr YoY | βΉ8 Cr QoQ
EPS: βΉ3.08 β8% YoY | β20% QoQ
KFIN TECH says
Stick To EBITDA Margin Guidance Of 40-45% For FY27
Stick To EBITDA Margin Guidance Of 40-45% For FY27
β€1
Morepen Laboratories Ltd β RECORD Q2 REVENUE AND EBITDA
Financial results for the quarter and half year ended September 30, 2026:
- Q2 FY27 Revenue: INR 755 Cr, up 81% YoY
- Q2 FY27 EBITDA: INR 132 Cr, up 273% YoY
- Q2 FY27 PAT: INR 89 Cr, up 117% YoY
- Q2 CDMO Revenue: INR 253 Cr (52% of API + CDMO revenue)
- Q2 Exports: INR 397 Cr, up 131% YoY
- Q2 Medical Devices: INR 208 Cr, up 65% YoY
Financial results for the quarter and half year ended September 30, 2026:
- Q2 FY27 Revenue: INR 755 Cr, up 81% YoY
- Q2 FY27 EBITDA: INR 132 Cr, up 273% YoY
- Q2 FY27 PAT: INR 89 Cr, up 117% YoY
- Q2 CDMO Revenue: INR 253 Cr (52% of API + CDMO revenue)
- Q2 Exports: INR 397 Cr, up 131% YoY
- Q2 Medical Devices: INR 208 Cr, up 65% YoY
β€1
BBL: Q2 SL NET PROFIT 460M RUPEES VS 282M (YOY)
BBL: Q2 EBITDA 587M RUPEES VS 348M (YOY); Q2 EBITDA MARGIN 7.98% VS 7.35% (YOY)
BBL: Q2 REVENUE 7.36B RUPEES VS 4.73B (YOY)
BBL: Q2 EBITDA 587M RUPEES VS 348M (YOY); Q2 EBITDA MARGIN 7.98% VS 7.35% (YOY)
BBL: Q2 REVENUE 7.36B RUPEES VS 4.73B (YOY)